학술논문

Phenotypic High-Risk Disease in the Context of Carfilzomib and Lenalidomide Combination Induction Therapy for Newly Diagnosed Transplant-Eligible Myeloma Patients
Document Type
Journal
Source
BLOOD; NOV 23 2021, 138 5p. Supplement: 1
Subject
Language
English
ISSN
15280020